期刊文献+

无创肝纤维化诊断研究现状与前景 被引量:10

Current status and prospects of research on noninvasive diagnosis of liver fibrosis
下载PDF
导出
摘要 肝纤维化是许多慢性肝病进展为肝硬化、肝癌的共同病理过程,肝穿刺活组织检查作为准确度最高的确诊手段因各种弊端而不能成为常规检查方法。介绍了临床上较为实用的血清学与影像学方法,并分析了其各自的优缺点及研究现状。认为经过专家学者们的不断探索,无创诊断方法的地位日益凸显,在不久的将来有望取代肝活组织检查,成为确诊肝纤维化的有效手段。 Liver fibrosis is a common pathological process in the progression of various chronic liver diseases to liver cirrhosis and liver cancer,and liver biopsy with the highest accuracy in diagnosis cannot be used as a routine examination due to several drawbacks. This article introduces several serological and imaging methods used in clinical practice and analyzes their advantages/disadvantages and the current status of research. It is believed that thanks to the efforts of experts and scholars,noninvasive diagnostic methods have become more and more important and may replace liver biopsy and become an effective method for the diagnosis of liver fibrosis in the near future.
作者 郑少秋 王启之 ZHENG Shaoqiu;WANG Qizhi(Department of Gastroenterology,The First Affiliated Hospital of Bengbu Medical College,Bengbu,Anhui 233000,China)
出处 《临床肝胆病杂志》 CAS 北大核心 2019年第1期197-200,共4页 Journal of Clinical Hepatology
关键词 肝硬化 诊断 综述 liver cirrhosis diagnosis review
  • 相关文献

参考文献11

二级参考文献71

  • 1王同兴,于卫叶.联合检测血清PCⅢ,HA,LN对肝纤维化的诊断价值[J].医学信息(医学与计算机应用),2016,29(28):217-218. 被引量:2
  • 2袁利超,邵金华,郝美娜,李程,王贵萍,王泰龄,罗建文,白净,马安林.肝脏硬度测定仪FibroTouch与FibroScan和肝脏病理分期的相关性[J].中华肝脏病杂志,2014,22(6). 被引量:44
  • 3Lai CL,Shouval D,Lok AS,陈楠(摘译),张占卿(审校).恩替卡韦与拉米夫定治疗HBeAg阴性慢性乙型肝炎的对照研究[J].世界感染杂志,2006,6(4):396-396. 被引量:201
  • 4Liaw YF, Leung N, Guan R, et al. Asian-Pacific on the management of chronic hepatitis B: a 2005update[J]. Liver Int, 2005, 25(3): 472 - 489.
  • 5Sung JJ, Tsoi KK, Wong VW, et al. Meta-analysis: treatment of hepatitisB infection reduces risk of hepatocellular carcinoma[J]. Aliment PharmacolTher, 2008, 28 (9): 1067 - 1077.
  • 6Mok TS, Yeo W, Yu S, et al. An intensive surveillance programdetected a high incidence of hepatocellular carcinoma among hepatitisB virus carriers with abnormal alpha-fetoprotein levels or abdominal ultrasonography results[J]. J Clin Oncol, 2005, 23 (31): 8041-8047.
  • 7Wong GL, Wong VW, Tan GM, et al. Surveillance programmeforhepatocellular carcinoma improves the survival of patients withchronic viral hepatitis[J]. Liver Int, 2008, 28 (1): 79-87.
  • 8Imbert-Bismut F, Ratziu V, Pieroni L, et al. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study[J]. Lancet, 2001, 357(9262): 1069-1075.
  • 9Rosenberg WM, Voelker M, Thiel R, et al. Serum markers detect the presence of liver fibrosis: a cohort study[J]. Gastroenterology, 2004, 127(6): 1704-1713.
  • 10Zeng MD, Lu LG, Mao YM, et al. Prediction of significant fibrosis in HBeAg-positive patients with chronic hepatitis B by a noninvasive model[J]. Hepatulogy, 2005, 42(6): 1437-1445.

共引文献1217

同被引文献101

引证文献10

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部